CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Xeris Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: XERIS | Xeris Pharmaceuticals | Xeris Pharmaceuticals, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 1, 2013

First marketed drug

Jun 1, 2005

First NDA

Dec 30, 2021

Last known activity

Apr 21, 2023

Timeline

1950s

  1. Jul 22, 1958

    diclofenamide— Marketing Organization

2000s

  1. Jun 1, 2005

    Xeris Pharmaceuticals— Founded

2020s

  1. Jul 24, 2021

    Strongbridge Biopharma— Acquired

  2. Dec 30, 2021

    levoketoconazole— NDA Secondary Org

  3. Dec 30, 2021

    levoketoconazole— NDA Organization

Drugs by trial phase (7 distinct, 25 trials)

Phase 3 (1 own, 1 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (0 own, 1 via acquisition)

Indications

Studied for

Marketed drugs (3)

Subsidiaries (1 direct, 2 total across the full acquisition tree)

Recent trials (20)

Details

Founded
Chicago, IL, US Jun 1, 2005
First NDA
Dec 30, 2021
Last known activity
Apr 21, 2023

Designations held

  • Orphan drug